| A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 (NCT05737940) | AstraZeneca | 2023-04-24 |
| Tislelizumab Monotherapy or Combined With Lenvatinib as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma. (NCT05807776) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-24 |
| Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma (NCT05925413) | Eastern Hepatobiliary Surgery Hospital | 2023-04-24 |
| A Study of TY-1091 in Patients With Advanced Solid Tumors (NCT05675605) | TYK Medicines, Inc | 2023-04-24 |
| Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit (NCT05828758) | Sohag University | 2023-04-24 |
| Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer (NCT05744687) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-04-24 |
| Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma (NCT05823246) | Qilu Pharmaceutical Co., Ltd. | 2023-04-24 |
| TherApeutics in Early ProState Cancer (TAPS02) (NCT05191680) | Cambridge University Hospitals NHS Foundation Trust | 2023-04-24 |
| Second-line Treatment of Metastatic Colorectal Cancer (NCT06242067) | Qilu Hospital of Shandong University | 2023-04-23 |
| External Body Pressure in Heart Failure With Preserved Ejection Fraction (NCT05764564) | Duke University | 2023-04-21 |
| Endocalyx for Heart Failure (NCT05966415) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-04-21 |
| Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05813626) | Zhejiang Cancer Hospital | 2023-04-21 |
| D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT) (NCT05591677) | The Alfred | 2023-04-21 |
| A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma (NCT05805501) | Hoffmann-La Roche | 2023-04-21 |
| A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) (NCT05557591) | Regeneron Pharmaceuticals | 2023-04-21 |
| ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer (NCT05071937) | Alexander B Olawaiye, MD | 2023-04-21 |
| A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities (NCT05850286) | Institute of Hematology & Blood Diseases Hospital, China | 2023-04-21 |
| Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK (NCT05973253) | Isfahan University of Medical Sciences | 2023-04-21 |
| Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) (NCT05534750) | Assistance Publique - Hôpitaux de Paris | 2023-04-20 |
| A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors (NCT05785039) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-04-20 |
| The Effects of the GOLO for Life® Plan and Release Supplement on Weight Management in Overweight and Obese Adults (NCT05844631) | Golo | 2023-04-20 |
| Intravenous Iron Infusion on Chemotherapy-induced Anemia (NCT05299411) | Korea University Guro Hospital | 2023-04-20 |
| Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History (NCT05446584) | University of Texas Southwestern Medical Center | 2023-04-20 |
| Exercise to Improve Brain Health in Older African Americans (NCT05597124) | Rutgers, The State University of New Jersey | 2023-04-20 |
| PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer (NCT06792162) | Peking University Third Hospital | 2023-04-20 |
| The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes (NCT05844644) | Golo | 2023-04-20 |
| Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study (NCT05753306) | Mayo Clinic | 2023-04-20 |
| Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer (NCT05709574) | University of Arizona | 2023-04-20 |
| A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV (NCT05779995) | Hangzhou Sciwind Biosciences Co., Ltd. | 2023-04-20 |
| PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB (NCT05685615) | BioVersys AG | 2023-04-20 |
| Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease (NCT05237388) | Duke University | 2023-04-20 |
| A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer (NCT05802342) | Qilu Pharmaceutical Co., Ltd. | 2023-04-20 |
| TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT05507541) | Mayo Clinic | 2023-04-19 |
| Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers (NCT05749549) | Shanghai Blueray Biopharma Co., Ltd. | 2023-04-19 |
| Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma (NCT05757466) | St. Petersburg State Pavlov Medical University | 2023-04-19 |
| A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) (NCT05816252) | Klus Pharma Inc. | 2023-04-19 |
| CAR- PRISM (PRecision Intervention Smoldering Myeloma) (NCT05767359) | Dana-Farber Cancer Institute | 2023-04-19 |
| A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies (NCT05796570) | Franziska Wachter | 2023-04-19 |
| Cannabidiol to Reduce Anxiety Reactivity (NCT05823753) | University of California, San Diego | 2023-04-19 |
| Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness (NCT05689034) | Peking Union Medical College Hospital | 2023-04-19 |
| Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer (NCT06702995) | Evopoint Biosciences Inc. | 2023-04-19 |
| Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor (NCT05103345) | Guangzhou Sinogen Pharmaceutical Co., Ltd | 2023-04-19 |
| Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA) (NCT05705167) | PharmaMar | 2023-04-19 |
| STOP-HER2: Stopping Trastuzumab in HER2+ MBC (NCT05721248) | Dana-Farber Cancer Institute | 2023-04-19 |
| A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation (NCT05357690) | Mayo Clinic | 2023-04-19 |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer (NCT05020860) | Baylor Breast Care Center | 2023-04-18 |
| Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (NCT05262270) | University of Texas Southwestern Medical Center | 2023-04-18 |
| Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients (NCT05817903) | Consorzio Oncotech | 2023-04-18 |
| A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer (NCT05678257) | NuCana plc | 2023-04-18 |
| An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients (NCT05501574) | TFF Pharmaceuticals, Inc. | 2023-04-18 |
| Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder (NCT05011266) | New York State Psychiatric Institute | 2023-04-18 |
| Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections (NCT05639647) | Pfizer | 2023-04-18 |
| Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy (NCT05597878) | Wake Forest University Health Sciences | 2023-04-18 |
| Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies (NCT05786924) | Institut de Recherches Internationales Servier | 2023-04-18 |
| VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors (NCT04796012) | University of Texas Southwestern Medical Center | 2023-04-18 |
| Study Exploring the Supportive Effect of Acarbose in Weight Management (NCT05934110) | Empros Pharma AB | 2023-04-18 |
| New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study (NCT04481204) | M.D. Anderson Cancer Center | 2023-04-18 |
| Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease (NCT05811442) | Beijing Joekai Biotechnology LLC | 2023-04-18 |
| Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa (NCT05819398) | Boehringer Ingelheim | 2023-04-17 |
| A Study of Telitacicept in Lupus Nephritis (NCT05680480) | RemeGen Co., Ltd. | 2023-04-17 |
| Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout (NCT05665699) | InventisBio Co., Ltd | 2023-04-17 |
| Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans (NCT05294263) | VA Office of Research and Development | 2023-04-17 |
| COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study (NCT05301881) | The Netherlands Cancer Institute | 2023-04-17 |
| Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) (NCT05629208) | Gilead Sciences | 2023-04-17 |
| A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy (NCT05707377) | BeOne Medicines | 2023-04-17 |
| First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors (NCT05768139) | Eli Lilly and Company | 2023-04-17 |
| Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults (NCT05713760) | Austin Institute for Clinical Research | 2023-04-17 |
| Study of TFX06 in Women With Advanced Breast Cancer. (NCT05927779) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2023-04-17 |
| Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients (NCT05959044) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-04-16 |
| Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation (NCT06324266) | Jinling Hospital, China | 2023-04-16 |
| Depressed Mood Improvement Through Nicotine Dosing 3 (NCT05746273) | Vanderbilt University Medical Center | 2023-04-15 |
| Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK ) (NCT05229055) | University of Monastir | 2023-04-15 |
| Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer (NCT05430347) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-15 |
| Pain and Anxiety Associated With Osseodensification (NCT07610317) | Ordu University | 2023-04-15 |
| Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension (NCT05746546) | Vanderbilt University Medical Center | 2023-04-15 |
| Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants (NCT05865041) | ASLAN Pharmaceuticals | 2023-04-14 |
| A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors (NCT05726864) | Elicio Therapeutics | 2023-04-14 |
| PanACEA - STEP2C -01 (NCT05807399) | Michael Hoelscher | 2023-04-14 |
| A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors (NCT05779163) | Nanjing Leads Biolabs Co.,Ltd | 2023-04-14 |
| Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors (NCT05689853) | Akeso | 2023-04-14 |
| A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults (NCT05827926) | ModernaTX, Inc. | 2023-04-14 |
| A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction (NCT07304843) | Umecrine Cognition AB | 2023-04-14 |
| A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. (NCT05668091) | Harlan M Krumholz | 2023-04-14 |
| MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer (NCT05462236) | AUM Biosciences Pte Ltd | 2023-04-14 |
| Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant (NCT05799079) | Sanjay Mohan | 2023-04-13 |
| RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure (NCT04395196) | Wayne State University | 2023-04-13 |
| A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma (NCT05755113) | QBiotics Group Limited | 2023-04-13 |
| A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer (NCT05645692) | Hoffmann-La Roche | 2023-04-13 |
| To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males (NCT06692465) | Suzhou Kintor Pharmaceutical Inc, | 2023-04-13 |
| A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer (NCT06202261) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-04-13 |
| A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy (NCT05737784) | Praxis Precision Medicines | 2023-04-13 |
| Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy (NCT07385040) | Shaheed Mohtarma Benazir Bhutto Institue of Trauma | 2023-04-13 |
| A Randomized Controlled Study Evaluating Modified Cup Anteversion Placement in Prevention of Postoperative Dislocation in Patients Undergoing Acetabular Tumor Resection and Reconstruction (NCT05593146) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-04-13 |
| NAD Augmentation in Diabetes Kidney Disease (NCT05759468) | Brigham and Women's Hospital | 2023-04-13 |
| To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF (NCT05483907) | Bridge Biotherapeutics, Inc. | 2023-04-12 |
| Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke (NCT05630586) | Aarhus University Hospital | 2023-04-12 |
| Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn (NCT05619289) | University of North Carolina, Chapel Hill | 2023-04-12 |
| Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical Study (NCT05685550) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-12 |
| Promising ROd-cone DYstrophy Gene therapY (NCT05748873) | SparingVision | 2023-04-12 |
| Venous Ethanol for Ventricular Tachycardia (NCT05511246) | The Methodist Hospital Research Institute | 2023-04-12 |